Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: Int J Cancer. 2013 Oct 29;134(8):1854–1861. doi: 10.1002/ijc.28523

Fig. 2.

Fig. 2

(see attached pdf).Risk of CIN2 or worse and CIN3 or worse among HIV seropositive and seronegative women during follow-up after abnormal cytology. P > 0.10 for all comparisons of HIV seropositive women except for CIN2 or worse results after ASCUS (P = 0.007).